Journal of Comparative Effectiveness Research
@journal-cer.bsky.social
The latest CER, RWE & HEOR for patients, researchers, policy makers & all stakeholders | IF: 2.5 | MEDLINE-indexed | from Becaris Publishing
Reposted by Journal of Comparative Effectiveness Research
Lessons from a pilot study on #AI coding and analysis of qualitative patient data | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Lessons from a pilot study on AI coding and analysis of qualitative patient data | Becaris Publishing
becarispublishing.com
December 19, 2025 at 12:26 PM
Lessons from a pilot study on #AI coding and analysis of qualitative patient data | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
From potential to practice: Global considerations for #AI in health system decision-making | becarispublishing.com/digital-cont...
From potential to practice: Global considerations for AI in health system decision-making | Becaris Publishing
becarispublishing.com
December 19, 2025 at 8:52 AM
From potential to practice: Global considerations for #AI in health system decision-making | becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
FDA finalizes long-awaited guidance on using real-world evidence for medical device decisions | Becaris Publishing becarispublishing.com/digital-cont...
FDA finalizes long-awaited guidance on using real-world evidence for medical device decisions | Becaris Publishing
becarispublishing.com
December 18, 2025 at 3:46 PM
FDA finalizes long-awaited guidance on using real-world evidence for medical device decisions | Becaris Publishing becarispublishing.com/digital-cont...
📢New article alert
“Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison”
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #MAIC #ITC #Oncology
“Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison”
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #MAIC #ITC #Oncology
Becaris Publishing
becarispublishing.com
December 18, 2025 at 4:03 PM
📢New article alert
“Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison”
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #MAIC #ITC #Oncology
“Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison”
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #MAIC #ITC #Oncology
📢New article alert
“Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #COPD #CostEffectiveness #HEOR
“Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #COPD #CostEffectiveness #HEOR
Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease
Aim: Two fixed-dose combination triple therapies, budesonide/glycopyrronium/formoterol
fumarate dihydrate (BGF) 320/14.4/10 μg and fluticasone furoate/umeclidinium/vilanterol
(FF/UMEC/VI) 100/62....
becarispublishing.com
December 18, 2025 at 1:06 PM
📢New article alert
“Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #COPD #CostEffectiveness #HEOR
“Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #COPD #CostEffectiveness #HEOR
Reposted by Journal of Comparative Effectiveness Research
VIDEO: Most-favored nation pricing: Updates and strategic insights from Tim Wright, Genesis Research Group | Becaris Publishing becarispublishing.com/digital-cont...
VIDEO: Most-favored nation pricing: Updates and strategic insights from Tim Wright, Genesis Research Group | Becaris Publishing
becarispublishing.com
December 18, 2025 at 12:17 PM
VIDEO: Most-favored nation pricing: Updates and strategic insights from Tim Wright, Genesis Research Group | Becaris Publishing becarispublishing.com/digital-cont...
📢New article alert
New Short Report on “Acceptability of external control-arm use in non-oncology health technology assessment submissions”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HTA #RWE #ExternalControls #Methodology
New Short Report on “Acceptability of external control-arm use in non-oncology health technology assessment submissions”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HTA #RWE #ExternalControls #Methodology
Acceptability of external control-arm use in nononcology health technology assessment submissions
Aim: This study assessed the acceptability of external control-arm (ECA) use in nononcology
health technology assessment (HTA) submissions in Europe. Materials & methods: We conducted a sequential...
becarispublishing.com
December 18, 2025 at 10:00 AM
📢New article alert
New Short Report on “Acceptability of external control-arm use in non-oncology health technology assessment submissions”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HTA #RWE #ExternalControls #Methodology
New Short Report on “Acceptability of external control-arm use in non-oncology health technology assessment submissions”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HTA #RWE #ExternalControls #Methodology
Reposted by Journal of Comparative Effectiveness Research
How #AI assisted screening can improve efficiency and accuracy in targeted literature reviews | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
How AI-assisted screening can improve efficiency and accuracy in targeted literature reviews | Becaris Publishing
becarispublishing.com
December 18, 2025 at 8:40 AM
How #AI assisted screening can improve efficiency and accuracy in targeted literature reviews | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
📢New article alert
In two new Research Articles, researchers examine real-world patterns of care, utilization and outcomes in significant tricuspid regurgitation
🔗 becarispublishing.com/doi/10.57264...
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #RWE #Cardiovascular #HEOR
In two new Research Articles, researchers examine real-world patterns of care, utilization and outcomes in significant tricuspid regurgitation
🔗 becarispublishing.com/doi/10.57264...
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #RWE #Cardiovascular #HEOR
December 17, 2025 at 4:03 PM
📢New article alert
In two new Research Articles, researchers examine real-world patterns of care, utilization and outcomes in significant tricuspid regurgitation
🔗 becarispublishing.com/doi/10.57264...
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #RWE #Cardiovascular #HEOR
In two new Research Articles, researchers examine real-world patterns of care, utilization and outcomes in significant tricuspid regurgitation
🔗 becarispublishing.com/doi/10.57264...
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #RWE #Cardiovascular #HEOR
📢New article alert
“Effectiveness of motor relearning program in sit-to-stand transfer and activities of daily living among chronic stroke patients – a prospective, multicenter, randomized controlled trial”
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Stroke #ClinicalTrial
“Effectiveness of motor relearning program in sit-to-stand transfer and activities of daily living among chronic stroke patients – a prospective, multicenter, randomized controlled trial”
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Stroke #ClinicalTrial
Effectiveness of motor relearning program in sit-to-stand transfer and activities of daily living among chronic stroke patients – a prospective, multicenter, randomized controlled trial
Aim: Stroke is a clinically defined syndrome characterized by an acute, focal neurological
deficit due to vascular injury. Strokes can result in various disabilities, including
sensory and motor abnor...
becarispublishing.com
December 17, 2025 at 1:28 PM
📢New article alert
“Effectiveness of motor relearning program in sit-to-stand transfer and activities of daily living among chronic stroke patients – a prospective, multicenter, randomized controlled trial”
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Stroke #ClinicalTrial
“Effectiveness of motor relearning program in sit-to-stand transfer and activities of daily living among chronic stroke patients – a prospective, multicenter, randomized controlled trial”
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Stroke #ClinicalTrial
Reposted by Journal of Comparative Effectiveness Research
WEBINAR: Beyond borders: The global policy forces transforming pharma pricing and #marketaccess – January 27, 2026 | becarispublishing.com/digital-cont...
WEBINAR: Beyond borders: The global policy forces transforming pharma pricing and market access – January 27, 2026 | Becaris Publishing
becarispublishing.com
December 17, 2025 at 11:53 AM
WEBINAR: Beyond borders: The global policy forces transforming pharma pricing and #marketaccess – January 27, 2026 | becarispublishing.com/digital-cont...
📢New article alert
New Research Article on “Impact of lymph node dissection on overall survival and cancer-specific survival in elderly patients with early-stage non-small cell lung cancer: a SEER database analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #RWD
New Research Article on “Impact of lymph node dissection on overall survival and cancer-specific survival in elderly patients with early-stage non-small cell lung cancer: a SEER database analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #RWD
Impact of lymph node dissection on overall survival and cancer-specific survival in elderly patients with early-stage non-small cell lung cancer: a SEER database analysis
Aim: The aim of the study is to understand the impact of lymph node dissection (LND) on
overall survival (OS) and cancer-specific survival (CSS) in elderly patients with
early-stage non-small cell lun...
becarispublishing.com
December 17, 2025 at 10:38 AM
📢New article alert
New Research Article on “Impact of lymph node dissection on overall survival and cancer-specific survival in elderly patients with early-stage non-small cell lung cancer: a SEER database analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #RWD
New Research Article on “Impact of lymph node dissection on overall survival and cancer-specific survival in elderly patients with early-stage non-small cell lung cancer: a SEER database analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #NSCLC #RWD
📢New article alert
New Methodology on “Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HTA #NMA #CER #BayesianStatistics #HEOR
New Methodology on “Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HTA #NMA #CER #BayesianStatistics #HEOR
Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers
Aim: Fractional Polynomial (FP) models are widely used in survival analysis for health
technology assessment and network meta-analysis (NMA). However, current implementations
rely on a fixed set of pr...
becarispublishing.com
December 16, 2025 at 4:01 PM
📢New article alert
New Methodology on “Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HTA #NMA #CER #BayesianStatistics #HEOR
New Methodology on “Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #HTA #NMA #CER #BayesianStatistics #HEOR
📢New article alert
New PLSP on Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trial.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #PLSP #PKU #RareDisease #PlainLanguage
New PLSP on Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trial.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #PLSP #PKU #RareDisease #PlainLanguage
Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trial
What is this summary about? This plain language summary is based on an article about the APHENITY trial that was
published in The Lancet journal in October 2024. The APHENITY trial was a phase 3 clini...
becarispublishing.com
December 16, 2025 at 1:05 PM
📢New article alert
New PLSP on Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trial.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #PLSP #PKU #RareDisease #PlainLanguage
New PLSP on Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trial.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #PLSP #PKU #RareDisease #PlainLanguage
Reposted by Journal of Comparative Effectiveness Research
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | Becaris Publishing
becarispublishing.com
December 16, 2025 at 7:35 AM
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
Overcoming barriers to #cellandgenetherapy adoption with #realworldevidence | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Overcoming barriers to cell and gene therapy adoption with real-world evidence | Becaris Publishing
becarispublishing.com
December 15, 2025 at 9:09 AM
Overcoming barriers to #cellandgenetherapy adoption with #realworldevidence | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
What makes evidence matter? Examining the #realworldevidence decision paradox | becarispublishing.com/digital-cont...
What makes evidence matter? Examining the real-world evidence decision paradox | Becaris Publishing
becarispublishing.com
December 12, 2025 at 10:27 AM
What makes evidence matter? Examining the #realworldevidence decision paradox | becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
WEBINAR: Beyond borders: The global policy forces transforming pharma pricing and market access – January 27, 2026 | becarispublishing.com/digital-cont...
WEBINAR: Beyond borders: The global policy forces transforming pharma pricing and market access – January 27, 2026 | Becaris Publishing
becarispublishing.com
December 12, 2025 at 7:46 AM
WEBINAR: Beyond borders: The global policy forces transforming pharma pricing and market access – January 27, 2026 | becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
Overcoming barriers to cell and gene therapy adoption with #realworldevidence | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Overcoming barriers to cell and gene therapy adoption with real-world evidence | Becaris Publishing
becarispublishing.com
December 11, 2025 at 9:43 AM
Overcoming barriers to cell and gene therapy adoption with #realworldevidence | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
Hot off the press: Our pick of articles within #HTA and #RWE published in November 2025 | Becaris Publishing becarispublishing.com/digital-cont...
Hot off the press: Our pick of articles within HTA and RWE published in November 2025 | Becaris Publishing
becarispublishing.com
December 10, 2025 at 2:37 PM
Hot off the press: Our pick of articles within #HTA and #RWE published in November 2025 | Becaris Publishing becarispublishing.com/digital-cont...
📢New article alert
New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #OAB #PatientSafety #HEOR
New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #OAB #PatientSafety #HEOR
Becaris Publishing
becarispublishing.com
December 10, 2025 at 10:45 AM
📢New article alert
New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #OAB #PatientSafety #HEOR
New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #OAB #PatientSafety #HEOR
Reposted by Journal of Comparative Effectiveness Research
#Quantum technologies in #medicine: Canada–UK leaders explore adoption pathways, #biomedical applications, and opportunities for #GlobalCollaboration | Becaris Publishing becarispublishing.com/digital-cont...
Quantum technologies in medicine: Canada–UK leaders explore adoption pathways, biomedical applications, and opportunities for global collaboration | Becaris Publishing
becarispublishing.com
December 10, 2025 at 10:42 AM
#Quantum technologies in #medicine: Canada–UK leaders explore adoption pathways, #biomedical applications, and opportunities for #GlobalCollaboration | Becaris Publishing becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
Lessons from a pilot study on #AI coding and analysis of qualitative patient data | @thermofishersci.bsky.social #ISPOREurope becarispublishing.com/digital-cont...
Lessons from a pilot study on AI coding and analysis of qualitative patient data | Becaris Publishing
becarispublishing.com
December 10, 2025 at 9:47 AM
Lessons from a pilot study on #AI coding and analysis of qualitative patient data | @thermofishersci.bsky.social #ISPOREurope becarispublishing.com/digital-cont...
Reposted by Journal of Comparative Effectiveness Research
Rethinking global pricing strategies through the most-favored nation lens | becarispublishing.com/digital-cont...
Rethinking global pricing strategies through the most-favored nation lens | Becaris Publishing
becarispublishing.com
December 9, 2025 at 12:23 PM
Rethinking global pricing strategies through the most-favored nation lens | becarispublishing.com/digital-cont...
📢New article alert
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis
Aim: The use of amyloid-beta (Aβ) clearance to support regulatory approvals of drugs in
Alzheimer’s disease (AD) remains controversial. We evaluate Aβ as a potential trial-level
surrogate endpoint for...
becarispublishing.com
December 9, 2025 at 10:34 AM
📢New article alert
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints